EMvision Medical Devices (ASX:EMV) Change In Receivables: A$0.00 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ASX:EMV EMvision Medical Devices Ltd ASX:EMV
20 GF Score
Price A$1.53
! 3 Warning Signs
View Full Analysis

What is EMvision Medical Devices Change In Receivables?

EMvision Medical Devices ASX:EMV 20 Change In Receivables is A$0.00 Mil as of Dec. 2025. GuruFocus rates ASX:EMV with a GF Score™ of 20/100. The stock has 3 warning signs investors should review.

EMvision Medical Devices's change in receivables for the quarter that ended in Dec. 2025 was A$0.00 Mil. It means EMvision Medical Devices's Accounts Receivable stayed the same from Jun. 2025 to Dec. 2025 .

EMvision Medical Devices's change in receivables for the fiscal year that ended in Jun. 2025 was A$0.00 Mil. It means EMvision Medical Devices's Accounts Receivable stayed the same from Jun. 2024 to Jun. 2025 .

EMvision Medical Devices's Accounts Receivable for the quarter that ended in Dec. 2025 was A$5.75 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. EMvision Medical Devices's liquidation value for the six months ended in Dec. 2025 was A$16.67 Mil.

EMvision Medical Devices  (ASX:EMV) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

EMvision Medical Devices's Days Sales Outstanding for the quarter that ended in Dec. 2025 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=5.746/0*91
=

2. In Ben Graham's calculation of liquidation value, EMvision Medical Devices's accounts receivable are only considered to be worth 75% of book value:

EMvision Medical Devices's liquidation value for the quarter that ended in Dec. 2025 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=17.56-5.203+0.75 * 5.746+0.5 * 0
=16.67

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

EMvision Medical Devices Change In Receivables Related Terms

EMvision Medical Devices Change In Receivables Historical Data

* Premium members only.

The historical data trend for EMvision Medical Devices's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

EMvision Medical Devices Change In Receivables Chart

EMvision Medical Devices Annual Data
Trend Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Change In Receivables
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

EMvision Medical Devices Semi-Annual Data
Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
ASX:EMV
20GF Score
EMvision Medical Devices Ltd ASX:EMV
Change In Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

EMvision Medical Devices Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Receivables →
What does a Change In Receivables of A$0.00 Mil mean?
EMvision Medical Devices (ASX:EMV) has a Change In Receivables of A$0.00 Mil as of Dec. 2025. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for EMvision Medical Devices and its competitors.
Is EMvision Medical Devices' Change In Receivables too high?
EMvision Medical Devices' current Change In Receivables is A$0.00 Mil. Overall, EMvision Medical Devices has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does EMvision Medical Devices' Change In Receivables compare to ABT and SYK?
EMvision Medical Devices' Change In Receivables of A$0.00 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Receivables for a Medical Devices & Instruments company?
A good Change In Receivables depends on the Medical Devices & Instruments industry context. However, Change In Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Receivables mean?
A high Change In Receivables can signal that a stock is expensive relative to its fundamentals. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for EMvision Medical Devices and its competitors. EMvision Medical Devices's current Change In Receivables is A$0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EMvision Medical Devices stock overvalued right now?
EMvision Medical Devices (ASX:EMV) has a current Change In Receivables of A$0.00 Mil. The current Change In Receivables is A$0.00 Mil. EMvision Medical Devices' overall GF Score™ is 20/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Receivables calculated?
Change In Receivables is calculated from a company's financial statements. For EMvision Medical Devices (ASX:EMV), the current Change In Receivables is A$0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

EMvision Medical Devices Business Description

Address 65 Epping Road, Suite 4.01, Macquarie Park, Sydney, NSW, AUS, 2113
EMvision Medical Devices Ltd is an Australian medical device company. The company is focused on the research and development, and commercialisation of neurodiagnostic technology for stroke diagnosis and monitoring, as well as other medical imaging needs. Its focus is portable, cost-effective, and non-invasive brain scanners, including a bedside device (emu) and an ultra-lightweight pre-hospital device (First Responder). Its first indication targets acute stroke care, with a second planned indication in traumatic brain injury.
20GF Score

Get the complete analysis for ASX:EMV

Change In Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$1.53
Price